The Safety and Effectiveness of PROCRIT (Epoetin Alfa) in Patients Undergoing Elective Major Abdominal and/or Pelvic Surgery

NCT00350519 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

37

Enrollment

INDUSTRY

Sponsor class

Stopped The study was stopped due to slow enrollment

Conditions

Hemostasis, Surgical

Interventions

DRUG: Epoetin alfa
DRUG: Standard of Care

Sponsor

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Collaborators

[object Object]